New CT scoring aims to better detect smell loss in allergy patients

NCT ID NCT07380945

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test a new way to score CT scans to see how well it measures smell loss in people with central compartment atopic disease (CCAD), a type of nasal allergy. Researchers will compare the new scoring system to the traditional one in 120 participants. The goal is to improve diagnosis and understanding of smell problems in these patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a more accurate way to measure smell loss in CCAD patients using CT scans.

What could go wrong

This is an early observational study, not a treatment trial. The new scoring system may not prove better than existing methods.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic rhinosinusitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Otolaryngology Head and Neck Surgery, Peking University Third Hospital

    Beijing, People's Republic of China, 10019, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••